p53 in embryonic development: Maintaining a fine balance

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 38-47

  Choi, J ^a   Donehower, L A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle; Differentiation; Embryonic development; Knockout mice; p53; Teratological suppressor; Tumour suppressor

Indexed keywords

PROTEIN P53;

CELL DIFFERENTIATION; CONGENITAL MALFORMATION; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO DEVELOPMENT; LETHALITY; MOUSE; NONHUMAN; REVIEW; STRESS; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; TERATOGENS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033027549     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050268     Document Type: Review

References (63)

1. 1 Jacks T. (1996) Tumor suppressor gene mutations in mice. Annu. Rev. Genet. 30: 603-636
2. 2 Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Butel J. S. et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221
3. 3 Rogel A., Popliker M., Webb C. G. and Oren M. (1985) p53 cellular tumour antigen: analysis of mRNA levels in adult tissues, embryos and tumours. Mol. Cell. Biol. 5: 2851-2855
4. 4 Louis J. M., McFarland V. W., May P. and Mora P. T. (1988) The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim. Biophys. Acta 950: 395-402
5. 5 Schmid P., Lorenz A., Hameister H. and Montenarh M. (1991) Expression of p53 during mouse embryogenesis. Development 113: 857-865
6. 6 Almog N. and Rotter V. (1997) Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta 1333: F1-F27
7. 7 Hall P. A. and Lane D. P. (1997) Tumour suppressors: a developing role for p53? Curr. Biol. 7: R144-R147
8. 8 Nicol C. J., Harrison M. L., Laposa R. R., Gimelshtein I. L. and Wells P. G. (1995) A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nature Genet. 10: 181-187
9. 9 Norimura T., Nomoto S., Katsuki M., Gondo Y. and Kondo S. (1996) p53-dependent apoptosis suppresses radiation-induced teralogenesis. Nature Med. 2: 577-580
10. 10 MacCallum D. E., Hupp T. R., Midgley C. A., Stuart D., Campbell S. J., Harper A. et al. (1996). The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 12: 2575-2587
11. 11 Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. et al. (1997) Transgenic mouse model for studying the transcriptional activity of the p53 protein: age-and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J. 16: 1381-1390
12. 12 Komarova E. A., Chernov M. V., Franks R., Wang K., Armin G., Zelnick C. R. et al. (1997) Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16: 1391-1400
13. 13 Lutzker S. G. and Levine A. J. (1996) A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature Med. 2: 804-810
14. 14 Shaulsky G., Goldfinger N., Peled A. and Rotter V. (1991) Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88: 8982-8986
15. 15 Shaulsky G., Goldfinger N. and Rotter V. (1991) Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins. Cancer Res. 51: 5232-5237
16. 16 Aloni-Grinstein R., Schwanz Y., Teitz N., Goldfinger N. and Rotter V. (1995) Accumulation of wild type p53 protein upon gamma-irradiation induces a G2-dependent immunoglobulin kappa light chain gene expression. EMBO J. 14: 1392-1401
17. 17 Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
18. 18 Jost C. A., Marin M. C. and Kaelin W. G. Jr. (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194
19. 19 Danska J. S., Pflumio F., Williams C. J., Huner O., Dick J. E. and Guidos C. J. (1994) Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266: 450-455
20. 20 Murphy W. J., Durum S. K., Anver M. R., Ferris D. K., McVicar D. W., O'Shea J. J. et al. (1994) Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). Immunology 153: 1004-1014
21. 21 Bogue M. A., Zhu C., Aguilar-Cordova F., Donehower L. A. and Roth D. B. (1996) p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10: 553-565
22. 22 Jacks T., Remington L., Williams B. O., Schmitt E. M., Halachmi S., Bronson R. T. et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7
23. 23 Purdie C. A., Harrison D. J., Peter A., Dobbie L., White S., Howie S. E. M. et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9: 603-609
24. 24 Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S., Yagi T. et al. (1993) Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8: 3313-3322
25. 25 Gondo Y., Nakamura K., Nakao K., Sasaoka T., Ito K., Kimura M. et al. (1994) Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination. Biochem. Biophys. Res. Commun. 202: 830-837
26. 26 Rotter V., Schwartz D., Almon E., Goldfinger N., Kapon A., Meshorer A. et al. (1993). Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. USA 90: 9075-9079
27. 27 Donehower L. A. (1996) The p53-deficient mouse: a model for basic and applied cancer studies. Sem. Cancer Biol. 7: 269-278
28. 28 Armstrong J. F., Kaufman M. H., Harrison D. J. and Clarke A. R. (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5: 931-936
29. 29 Sah V. P., Attardi L. D., Mulligan G. J., Williams B. O., Bronson R. T. and Jacks T. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10: 175-180
30. 30 Lavigueur A., Maltby V., Mock D., Rossant J., Pawson T. and Bernstein A. (1989) High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9: 3982-3991
31. 31 Harvey M., Vogel H., Morris D., Bradley A., Bernstein A. and Donehower L. A. (1995) A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9: 305-311
32. 32 Godley L. A., Kopp J. B., Eckhaus M., Paglino J. J., Owens J. and Varmus H. E. (1996). Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10: 836-850
33. 33 Nakamura T., Pichel J. G., Williams-Simons L. and Westphal H. (1995) An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc. Natl. Acad. Sci. USA 92: 6142-6146
34. 34 Li B., Greenberg N., Stephens L. C., Meyn R., Medina D. and Rosen J. M. (1994) Preferential overexpression of a 172Arg → Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ. 5: 711-721
35. 35 Li B., Kittrell F. S., Medina D. and Rosen J. M. (1995) Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein. Mol. Carcinog. 14: 75-83
36. 36 Hoever M., Clement J. H., Wedlich D., Montenarh M. and Knochel W. (1994) Overexpression of wild-type p53 interferes with normal development in Xenopus laeris embryos. Oncogene 9: 109-120
37. 37 Wallingford J. B., Seufert D. W., Virta V. C. and Vize P. D. (1997) p53 activity is essential for normal development in Xenopus. Curr. Biol. 7: 747-757
38. 38 Rudnicki M. A., Schnegelsberg P. N., Stead R. H., Braun T., Arnold H. H. and Jaenisch R. (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359
39. 39 Ko L. J. and C. Prives (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
40. 40 Gottlieb T. M. and Oren M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102
41. 41 Levine A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
42. 42 Jones S. N., Roe A. E., Donehower L. A. and Bradley A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208
43. 43 Montes de Oca Luna R., Wagner D. S. and Lozano G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206
44. 44 Lane D. P. and Hall P. A. (1997) MDM2 arbiter of p53's destruction. Trends Biochem. Sci. 22: 372-374
45. 45 Piette J., Neel H. and Marechal V. (1997) Mdm2: keeping p53 under control. Oncogene 15: 1001-1010
46. 46 Snow M. H. L. (1977) Gastrulation in the mouse: growth and regionalization of the epiblast. J. Embryol. Exp. Morph. 42: 293-303
47. 47 Montes de Oca Luna R., Amelse L. L., Chavez-Reyes A., Evans S. C., Brugarolas J., Jacks T. et al. (1997) Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality. Nature Genet. 16: 336-337
48. 48 Lim D. S. and Hasty P. (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16: 7133-7143
49. 49 Ivanov E. L. and Haber J. E. (1997) DNA repair: RAD alert. Curr. Biol. 7: R492-R495
50. 50 Sturzbecher H. W., Donzelmann B., Henning W., Knippschild U. and Buchhop S. (1996) p53 is linked directly to homologous recombination processes via RAD51 RecA protein interaction. EMBO J. 15: 1992-2002
51. 51 Buchhop S., Gibson M. K., Wang X. W., Wagner P., Sturzbecher H. W. and Harris C. C. (1997) Interaction of p53 with the human Rad51 protein. Nucleic Acids Res. 25: 3868-3874
52. 52 Ludwig T., Chapman D. L., Papaioannou V. E. and Efstratiadis A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11: 1226-1241
53. 53 Hakem R., de la Pompa J. L., Elia A., Potter J. and Mak T. W. (1997) Partial rescue of Brca1 (5 6) early embryonic lethality by p53 or p21 null mutation. Nature Genet. 16: 298-302
54. 54 Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J. et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275
55. 55 Sharan S. K., Morimatsu M., Albrecht U., Lim D. S., Regel E., Dinh C. et al. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810
56. 56 Hakem R., de la Pompa J. L., Sirard C., Mo R., Woo M., Hakem A. et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023
57. 57 Barlow C., Liyanage M., Moens P. B., Deng C. X., Ried T. and Wynshaw-Boris A. (1997) Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nature Genet. 17: 462-466
58. 58 Nacht M., Strasser A., Chan Y. R., Harris A. W., Schlissel M., Bronson R. T. et al. (1996) Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10: 2055-2066
59. 59 Guidos C. J., Williams C. J., Grandal I., Knowles G., Huang M. T. and Danska J. S. (1996) V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10: 2038-2054
60. 60 Wubah J. A., Ibrahim M. M., Gao X., Nguyen D., Pisano M. M. and Knudsen T. B. (1996) Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol. 6: 60-69
61. 61 Hupp T. R., Meek D. W., Midgley C. A. and Lane D. P. (1992) Regulation of the specific DNA binding function of p53. Cell 71: 875-886
62. 62 Cox L. S., Hupp T., Midgley C. A. and Lane D. P. (1995) A direct effect of activated human p53 on nuclear DNA replication. EMBO J. 14: 2099-2105
63. 63 Kubbutat M. H., Jones S. N. and Vousden K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303